nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP1A2—Carmustine—malignant glioma	0.356	0.569	CbGbCtD
Cilostazol—CYP3A4—Temozolomide—malignant glioma	0.269	0.43	CbGbCtD
Cilostazol—Cerebral infarction—Carmustine—malignant glioma	0.0108	0.0419	CcSEcCtD
Cilostazol—Retinal haemorrhage—Carmustine—malignant glioma	0.0108	0.0419	CcSEcCtD
Cilostazol—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00832	0.0321	CcSEcCtD
Cilostazol—Interstitial pneumonia—Temozolomide—malignant glioma	0.00706	0.0273	CcSEcCtD
Cilostazol—Cerebral ischaemia—Temozolomide—malignant glioma	0.00706	0.0273	CcSEcCtD
Cilostazol—Cerebral haemorrhage—Carmustine—malignant glioma	0.00638	0.0247	CcSEcCtD
Cilostazol—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00617	0.0238	CcSEcCtD
Cilostazol—Interstitial lung disease—Carmustine—malignant glioma	0.00499	0.0193	CcSEcCtD
Cilostazol—Thrombosis—Carmustine—malignant glioma	0.00499	0.0193	CcSEcCtD
Cilostazol—Interstitial lung disease—Temozolomide—malignant glioma	0.00482	0.0186	CcSEcCtD
Cilostazol—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00461	0.0178	CcSEcCtD
Cilostazol—Hyperaesthesia—Temozolomide—malignant glioma	0.00435	0.0168	CcSEcCtD
Cilostazol—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00415	0.016	CcSEcCtD
Cilostazol—Vaginal inflammation—Temozolomide—malignant glioma	0.00341	0.0132	CcSEcCtD
Cilostazol—Vaginal infection—Temozolomide—malignant glioma	0.00322	0.0125	CcSEcCtD
Cilostazol—Aplastic anaemia—Temozolomide—malignant glioma	0.00321	0.0124	CcSEcCtD
Cilostazol—Diabetes mellitus—Carmustine—malignant glioma	0.00295	0.0114	CcSEcCtD
Cilostazol—Ear pain—Temozolomide—malignant glioma	0.0029	0.0112	CcSEcCtD
Cilostazol—Gastroenteritis—Temozolomide—malignant glioma	0.0028	0.0108	CcSEcCtD
Cilostazol—Vascular purpura—Temozolomide—malignant glioma	0.00277	0.0107	CcSEcCtD
Cilostazol—Hot flush—Temozolomide—malignant glioma	0.00265	0.0102	CcSEcCtD
Cilostazol—Menopausal symptoms—Temozolomide—malignant glioma	0.00263	0.0101	CcSEcCtD
Cilostazol—Purpura—Temozolomide—malignant glioma	0.00257	0.00993	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00256	0.00991	CcSEcCtD
Cilostazol—Diplopia—Carmustine—malignant glioma	0.00256	0.00991	CcSEcCtD
Cilostazol—Diplopia—Temozolomide—malignant glioma	0.00248	0.00957	CcSEcCtD
Cilostazol—Face oedema—Carmustine—malignant glioma	0.00248	0.00956	CcSEcCtD
Cilostazol—Face oedema—Temozolomide—malignant glioma	0.00239	0.00924	CcSEcCtD
Cilostazol—Liver function test abnormal—Carmustine—malignant glioma	0.00237	0.00915	CcSEcCtD
Cilostazol—Dry skin—Temozolomide—malignant glioma	0.00227	0.00878	CcSEcCtD
Cilostazol—Pancytopenia—Carmustine—malignant glioma	0.00211	0.00813	CcSEcCtD
Cilostazol—Bronchitis—Temozolomide—malignant glioma	0.00206	0.00796	CcSEcCtD
Cilostazol—Pancytopenia—Temozolomide—malignant glioma	0.00203	0.00786	CcSEcCtD
Cilostazol—Pneumonia—Carmustine—malignant glioma	0.00199	0.00768	CcSEcCtD
Cilostazol—Pollakiuria—Temozolomide—malignant glioma	0.00198	0.00764	CcSEcCtD
Cilostazol—Urinary tract infection—Carmustine—malignant glioma	0.00192	0.00742	CcSEcCtD
Cilostazol—Pneumonia—Temozolomide—malignant glioma	0.00192	0.00742	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00189	0.00731	CcSEcCtD
Cilostazol—Urinary tract infection—Temozolomide—malignant glioma	0.00186	0.00717	CcSEcCtD
Cilostazol—Hepatobiliary disease—Temozolomide—malignant glioma	0.00181	0.00698	CcSEcCtD
Cilostazol—Sinusitis—Temozolomide—malignant glioma	0.00179	0.00692	CcSEcCtD
Cilostazol—Haemoglobin—Carmustine—malignant glioma	0.00178	0.00689	CcSEcCtD
Cilostazol—Haemorrhage—Carmustine—malignant glioma	0.00177	0.00685	CcSEcCtD
Cilostazol—Hypoaesthesia—Carmustine—malignant glioma	0.00177	0.00682	CcSEcCtD
Cilostazol—Oedema peripheral—Carmustine—malignant glioma	0.00175	0.00675	CcSEcCtD
Cilostazol—Haemoglobin—Temozolomide—malignant glioma	0.00172	0.00666	CcSEcCtD
Cilostazol—Haemorrhage—Temozolomide—malignant glioma	0.00171	0.00662	CcSEcCtD
Cilostazol—Hypoaesthesia—Temozolomide—malignant glioma	0.00171	0.00659	CcSEcCtD
Cilostazol—Pharyngitis—Temozolomide—malignant glioma	0.0017	0.00657	CcSEcCtD
Cilostazol—Oedema peripheral—Temozolomide—malignant glioma	0.00169	0.00652	CcSEcCtD
Cilostazol—Erythema multiforme—Temozolomide—malignant glioma	0.00162	0.00626	CcSEcCtD
Cilostazol—Tinnitus—Temozolomide—malignant glioma	0.0016	0.00618	CcSEcCtD
Cilostazol—Cardiac disorder—Temozolomide—malignant glioma	0.00159	0.00615	CcSEcCtD
Cilostazol—Angiopathy—Temozolomide—malignant glioma	0.00156	0.00601	CcSEcCtD
Cilostazol—Mediastinal disorder—Temozolomide—malignant glioma	0.00155	0.00597	CcSEcCtD
Cilostazol—Chills—Temozolomide—malignant glioma	0.00154	0.00594	CcSEcCtD
Cilostazol—Back pain—Carmustine—malignant glioma	0.00149	0.00577	CcSEcCtD
Cilostazol—Back pain—Temozolomide—malignant glioma	0.00144	0.00558	CcSEcCtD
Cilostazol—Anaemia—Carmustine—malignant glioma	0.00143	0.00551	CcSEcCtD
Cilostazol—Ill-defined disorder—Temozolomide—malignant glioma	0.00138	0.00535	CcSEcCtD
Cilostazol—Leukopenia—Carmustine—malignant glioma	0.00138	0.00534	CcSEcCtD
Cilostazol—Anaemia—Temozolomide—malignant glioma	0.00138	0.00533	CcSEcCtD
Cilostazol—Malaise—Temozolomide—malignant glioma	0.00135	0.0052	CcSEcCtD
Cilostazol—Vertigo—Temozolomide—malignant glioma	0.00134	0.00518	CcSEcCtD
Cilostazol—Leukopenia—Temozolomide—malignant glioma	0.00134	0.00516	CcSEcCtD
Cilostazol—Hypertension—Carmustine—malignant glioma	0.00133	0.00515	CcSEcCtD
Cilostazol—Palpitations—Temozolomide—malignant glioma	0.00132	0.0051	CcSEcCtD
Cilostazol—Chest pain—Carmustine—malignant glioma	0.00131	0.00508	CcSEcCtD
Cilostazol—Myalgia—Carmustine—malignant glioma	0.00131	0.00508	CcSEcCtD
Cilostazol—Anxiety—Carmustine—malignant glioma	0.00131	0.00506	CcSEcCtD
Cilostazol—Cough—Temozolomide—malignant glioma	0.0013	0.00503	CcSEcCtD
Cilostazol—Hypertension—Temozolomide—malignant glioma	0.00129	0.00498	CcSEcCtD
Cilostazol—Arthralgia—Temozolomide—malignant glioma	0.00127	0.00491	CcSEcCtD
Cilostazol—Myalgia—Temozolomide—malignant glioma	0.00127	0.00491	CcSEcCtD
Cilostazol—Anxiety—Temozolomide—malignant glioma	0.00127	0.00489	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00126	0.00487	CcSEcCtD
Cilostazol—Oedema—Carmustine—malignant glioma	0.00126	0.00487	CcSEcCtD
Cilostazol—Discomfort—Temozolomide—malignant glioma	0.00126	0.00485	CcSEcCtD
Cilostazol—Infection—Carmustine—malignant glioma	0.00125	0.00484	CcSEcCtD
Cilostazol—Thrombocytopenia—Carmustine—malignant glioma	0.00123	0.00477	CcSEcCtD
Cilostazol—Tachycardia—Carmustine—malignant glioma	0.00123	0.00475	CcSEcCtD
Cilostazol—Oedema—Temozolomide—malignant glioma	0.00122	0.00471	CcSEcCtD
Cilostazol—Infection—Temozolomide—malignant glioma	0.00121	0.00467	CcSEcCtD
Cilostazol—Anorexia—Carmustine—malignant glioma	0.0012	0.00464	CcSEcCtD
Cilostazol—Nervous system disorder—Temozolomide—malignant glioma	0.00119	0.00461	CcSEcCtD
Cilostazol—Thrombocytopenia—Temozolomide—malignant glioma	0.00119	0.00461	CcSEcCtD
Cilostazol—Skin disorder—Temozolomide—malignant glioma	0.00118	0.00457	CcSEcCtD
Cilostazol—Hypotension—Carmustine—malignant glioma	0.00118	0.00455	CcSEcCtD
Cilostazol—Anorexia—Temozolomide—malignant glioma	0.00116	0.00449	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00115	0.00444	CcSEcCtD
Cilostazol—Insomnia—Carmustine—malignant glioma	0.00114	0.0044	CcSEcCtD
Cilostazol—Paraesthesia—Carmustine—malignant glioma	0.00113	0.00437	CcSEcCtD
Cilostazol—Dyspnoea—Carmustine—malignant glioma	0.00112	0.00434	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00111	0.00429	CcSEcCtD
Cilostazol—Insomnia—Temozolomide—malignant glioma	0.0011	0.00426	CcSEcCtD
Cilostazol—Decreased appetite—Carmustine—malignant glioma	0.0011	0.00423	CcSEcCtD
Cilostazol—Paraesthesia—Temozolomide—malignant glioma	0.00109	0.00423	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00109	0.0042	CcSEcCtD
Cilostazol—Dyspnoea—Temozolomide—malignant glioma	0.00109	0.0042	CcSEcCtD
Cilostazol—Pain—Carmustine—malignant glioma	0.00108	0.00416	CcSEcCtD
Cilostazol—Dyspepsia—Temozolomide—malignant glioma	0.00107	0.00414	CcSEcCtD
Cilostazol—Decreased appetite—Temozolomide—malignant glioma	0.00106	0.00409	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00105	0.00406	CcSEcCtD
Cilostazol—Pain—Temozolomide—malignant glioma	0.00104	0.00402	CcSEcCtD
Cilostazol—Feeling abnormal—Carmustine—malignant glioma	0.00104	0.00401	CcSEcCtD
Cilostazol—Gastrointestinal pain—Carmustine—malignant glioma	0.00103	0.00398	CcSEcCtD
Cilostazol—Feeling abnormal—Temozolomide—malignant glioma	0.001	0.00388	CcSEcCtD
Cilostazol—Abdominal pain—Carmustine—malignant glioma	0.000996	0.00385	CcSEcCtD
Cilostazol—Body temperature increased—Carmustine—malignant glioma	0.000996	0.00385	CcSEcCtD
Cilostazol—Gastrointestinal pain—Temozolomide—malignant glioma	0.000996	0.00385	CcSEcCtD
Cilostazol—Urticaria—Temozolomide—malignant glioma	0.000968	0.00374	CcSEcCtD
Cilostazol—Body temperature increased—Temozolomide—malignant glioma	0.000963	0.00372	CcSEcCtD
Cilostazol—Abdominal pain—Temozolomide—malignant glioma	0.000963	0.00372	CcSEcCtD
Cilostazol—Asthenia—Carmustine—malignant glioma	0.000904	0.00349	CcSEcCtD
Cilostazol—Asthenia—Temozolomide—malignant glioma	0.000874	0.00338	CcSEcCtD
Cilostazol—Diarrhoea—Carmustine—malignant glioma	0.000862	0.00333	CcSEcCtD
Cilostazol—Pruritus—Temozolomide—malignant glioma	0.000862	0.00333	CcSEcCtD
Cilostazol—Dizziness—Carmustine—malignant glioma	0.000834	0.00322	CcSEcCtD
Cilostazol—Diarrhoea—Temozolomide—malignant glioma	0.000833	0.00322	CcSEcCtD
Cilostazol—Dizziness—Temozolomide—malignant glioma	0.000806	0.00311	CcSEcCtD
Cilostazol—Vomiting—Carmustine—malignant glioma	0.000801	0.0031	CcSEcCtD
Cilostazol—Rash—Carmustine—malignant glioma	0.000795	0.00307	CcSEcCtD
Cilostazol—Dermatitis—Carmustine—malignant glioma	0.000794	0.00307	CcSEcCtD
Cilostazol—Headache—Carmustine—malignant glioma	0.00079	0.00305	CcSEcCtD
Cilostazol—Vomiting—Temozolomide—malignant glioma	0.000775	0.00299	CcSEcCtD
Cilostazol—Rash—Temozolomide—malignant glioma	0.000768	0.00297	CcSEcCtD
Cilostazol—Dermatitis—Temozolomide—malignant glioma	0.000767	0.00296	CcSEcCtD
Cilostazol—Headache—Temozolomide—malignant glioma	0.000763	0.00295	CcSEcCtD
Cilostazol—Nausea—Carmustine—malignant glioma	0.000749	0.00289	CcSEcCtD
Cilostazol—Nausea—Temozolomide—malignant glioma	0.000724	0.0028	CcSEcCtD
Cilostazol—PDE3A—GPCR downstream signaling—F2—malignant glioma	9.22e-05	0.000795	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCR3—malignant glioma	9.2e-05	0.000793	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.98e-05	0.000774	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NTRK2—malignant glioma	8.95e-05	0.000771	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—YWHAE—malignant glioma	8.95e-05	0.000771	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FLT1—malignant glioma	8.91e-05	0.000768	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—DUSP6—malignant glioma	8.87e-05	0.000764	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CG—malignant glioma	8.83e-05	0.00076	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JAG1—malignant glioma	8.76e-05	0.000755	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH3—malignant glioma	8.72e-05	0.000751	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—IDH2—malignant glioma	8.6e-05	0.000741	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FBXW7—malignant glioma	8.58e-05	0.000739	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BDKRB2—malignant glioma	8.41e-05	0.000725	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—F2—malignant glioma	8.37e-05	0.000722	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—VEGFA—malignant glioma	8.35e-05	0.00072	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ASMT—malignant glioma	8.2e-05	0.000707	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2B6—malignant glioma	8.09e-05	0.000697	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—AKT2—malignant glioma	8.07e-05	0.000696	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CG—malignant glioma	8.01e-05	0.000691	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PTPN11—malignant glioma	7.87e-05	0.000678	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH2—malignant glioma	7.82e-05	0.000674	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—RTEL1—malignant glioma	7.81e-05	0.000673	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CD—malignant glioma	7.76e-05	0.000668	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.72e-05	0.000666	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—BCAN—malignant glioma	7.71e-05	0.000665	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KNG1—malignant glioma	7.65e-05	0.00066	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.62e-05	0.000656	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—COX8A—malignant glioma	7.46e-05	0.000643	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—IDH1—malignant glioma	7.4e-05	0.000637	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT2—malignant glioma	7.33e-05	0.000632	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NTRK1—malignant glioma	7.29e-05	0.000629	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.23e-05	0.000623	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SPHK1—malignant glioma	7.16e-05	0.000617	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—KRAS—malignant glioma	7.1e-05	0.000612	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CD—malignant glioma	7.05e-05	0.000607	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2C18—malignant glioma	7.01e-05	0.000604	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7e-05	0.000603	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—COX8A—malignant glioma	6.86e-05	0.000591	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP3—malignant glioma	6.78e-05	0.000584	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CB—malignant glioma	6.76e-05	0.000583	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN2B—malignant glioma	6.72e-05	0.000579	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.67e-05	0.000575	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTK2—malignant glioma	6.53e-05	0.000562	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PIK3CA—malignant glioma	6.52e-05	0.000562	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—CXCL8—malignant glioma	6.5e-05	0.00056	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HES1—malignant glioma	6.41e-05	0.000553	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NCOR1—malignant glioma	6.38e-05	0.000549	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ASMT—malignant glioma	6.34e-05	0.000546	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—malignant glioma	6.31e-05	0.000544	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—RAF1—malignant glioma	6.29e-05	0.000542	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—IDH2—malignant glioma	6.22e-05	0.000536	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—IL2—malignant glioma	6.21e-05	0.000535	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.2e-05	0.000534	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CB—malignant glioma	6.14e-05	0.000529	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PDGFRA—malignant glioma	6.11e-05	0.000526	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BCAN—malignant glioma	5.96e-05	0.000514	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SPP1—malignant glioma	5.93e-05	0.000511	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—CXCL8—malignant glioma	5.9e-05	0.000508	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2B6—malignant glioma	5.85e-05	0.000504	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ASMT—malignant glioma	5.83e-05	0.000503	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—COX8A—malignant glioma	5.81e-05	0.000501	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTT1—malignant glioma	5.67e-05	0.000489	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL2—malignant glioma	5.64e-05	0.000486	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TERT—malignant glioma	5.62e-05	0.000484	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BCAN—malignant glioma	5.48e-05	0.000473	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PDGFB—malignant glioma	5.48e-05	0.000473	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGFR1—malignant glioma	5.46e-05	0.00047	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HIF1A—malignant glioma	5.37e-05	0.000463	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—IDH1—malignant glioma	5.35e-05	0.000461	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—AKT1—malignant glioma	5.33e-05	0.000459	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS1—malignant glioma	5.31e-05	0.000458	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CAV1—malignant glioma	5.2e-05	0.000448	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.2e-05	0.000448	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SPHK1—malignant glioma	5.17e-05	0.000446	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KDR—malignant glioma	5.14e-05	0.000443	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2C18—malignant glioma	5.07e-05	0.000437	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—F2—malignant glioma	4.95e-05	0.000426	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FN1—malignant glioma	4.95e-05	0.000426	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ASMT—malignant glioma	4.94e-05	0.000426	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—BCHE—malignant glioma	4.94e-05	0.000426	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BAD—malignant glioma	4.89e-05	0.000421	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SLC5A5—malignant glioma	4.88e-05	0.00042	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH1—malignant glioma	4.84e-05	0.000417	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.83e-05	0.000416	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—IDH2—malignant glioma	4.81e-05	0.000414	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CD80—malignant glioma	4.74e-05	0.000409	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—APC—malignant glioma	4.73e-05	0.000408	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CG—malignant glioma	4.73e-05	0.000408	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGF—malignant glioma	4.68e-05	0.000403	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTPN11—malignant glioma	4.65e-05	0.000401	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BCAN—malignant glioma	4.65e-05	0.0004	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.53e-05	0.000391	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2B6—malignant glioma	4.52e-05	0.000389	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—COX8A—malignant glioma	4.49e-05	0.000386	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BRAF—malignant glioma	4.45e-05	0.000383	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—IDH2—malignant glioma	4.42e-05	0.000381	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT2—malignant glioma	4.33e-05	0.000373	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EGFR—malignant glioma	4.31e-05	0.000372	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CD—malignant glioma	4.16e-05	0.000359	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.16e-05	0.000358	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—IDH1—malignant glioma	4.13e-05	0.000356	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CA—malignant glioma	4.12e-05	0.000355	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTT1—malignant glioma	4.1e-05	0.000353	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—KRAS—malignant glioma	4.07e-05	0.000351	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SPHK1—malignant glioma	4e-05	0.000345	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGF2—malignant glioma	3.98e-05	0.000343	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—malignant glioma	3.93e-05	0.000339	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.92e-05	0.000338	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS1—malignant glioma	3.84e-05	0.000331	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CAT—malignant glioma	3.82e-05	0.00033	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ASMT—malignant glioma	3.81e-05	0.000329	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—IDH1—malignant glioma	3.8e-05	0.000328	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—IDH2—malignant glioma	3.75e-05	0.000323	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CA—malignant glioma	3.74e-05	0.000323	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MDM2—malignant glioma	3.73e-05	0.000321	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RAF1—malignant glioma	3.72e-05	0.00032	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.69e-05	0.000318	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SPHK1—malignant glioma	3.68e-05	0.000317	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB2—malignant glioma	3.68e-05	0.000317	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CB—malignant glioma	3.63e-05	0.000313	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NCOR1—malignant glioma	3.61e-05	0.000311	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.6e-05	0.000311	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BCAN—malignant glioma	3.59e-05	0.000309	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—BCHE—malignant glioma	3.57e-05	0.000308	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.53e-05	0.000304	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.53e-05	0.000304	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.52e-05	0.000303	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCL8—malignant glioma	3.49e-05	0.0003	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—AKT1—malignant glioma	3.37e-05	0.00029	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.37e-05	0.00029	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CASP3—malignant glioma	3.34e-05	0.000287	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—malignant glioma	3.33e-05	0.000287	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.25e-05	0.00028	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—IDH1—malignant glioma	3.22e-05	0.000278	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—malignant glioma	3.17e-05	0.000273	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—malignant glioma	3.15e-05	0.000272	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTEN—malignant glioma	3.13e-05	0.00027	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SPHK1—malignant glioma	3.12e-05	0.000269	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT1—malignant glioma	3.06e-05	0.000264	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.05e-05	0.000263	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS1—malignant glioma	2.97e-05	0.000256	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.96e-05	0.000255	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CAV1—malignant glioma	2.94e-05	0.000254	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—malignant glioma	2.91e-05	0.000251	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH2—malignant glioma	2.89e-05	0.000249	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.88e-05	0.000248	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—malignant glioma	2.84e-05	0.000245	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—malignant glioma	2.83e-05	0.000244	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—malignant glioma	2.8e-05	0.000242	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAT—malignant glioma	2.76e-05	0.000238	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BCHE—malignant glioma	2.76e-05	0.000238	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS1—malignant glioma	2.73e-05	0.000235	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.73e-05	0.000235	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.72e-05	0.000234	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.68e-05	0.000231	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.62e-05	0.000226	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NCOR1—malignant glioma	2.61e-05	0.000225	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—malignant glioma	2.61e-05	0.000224	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PPARG—malignant glioma	2.59e-05	0.000223	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.58e-05	0.000222	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.56e-05	0.00022	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—malignant glioma	2.55e-05	0.00022	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BCHE—malignant glioma	2.54e-05	0.000219	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.53e-05	0.000218	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.51e-05	0.000216	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—IDH1—malignant glioma	2.49e-05	0.000214	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—malignant glioma	2.47e-05	0.000213	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—malignant glioma	2.41e-05	0.000207	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SPHK1—malignant glioma	2.41e-05	0.000207	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.36e-05	0.000203	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.36e-05	0.000203	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS1—malignant glioma	2.31e-05	0.000199	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.31e-05	0.000199	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.23e-05	0.000192	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—malignant glioma	2.21e-05	0.000191	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—malignant glioma	2.2e-05	0.000189	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BCHE—malignant glioma	2.15e-05	0.000185	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—malignant glioma	2.14e-05	0.000184	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAT—malignant glioma	2.14e-05	0.000184	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAV1—malignant glioma	2.13e-05	0.000183	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.12e-05	0.000183	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.06e-05	0.000177	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—malignant glioma	2.04e-05	0.000175	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—malignant glioma	2.02e-05	0.000174	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOR1—malignant glioma	2.02e-05	0.000174	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.01e-05	0.000173	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.99e-05	0.000172	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAT—malignant glioma	1.97e-05	0.000169	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.94e-05	0.000167	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—malignant glioma	1.91e-05	0.000164	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARG—malignant glioma	1.87e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOR1—malignant glioma	1.86e-05	0.00016	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—malignant glioma	1.81e-05	0.000156	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS1—malignant glioma	1.79e-05	0.000154	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—malignant glioma	1.78e-05	0.000153	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.74e-05	0.00015	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—malignant glioma	1.71e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.7e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAT—malignant glioma	1.67e-05	0.000144	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BCHE—malignant glioma	1.66e-05	0.000143	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAV1—malignant glioma	1.65e-05	0.000142	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.64e-05	0.000141	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOR1—malignant glioma	1.57e-05	0.000136	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.57e-05	0.000135	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAV1—malignant glioma	1.51e-05	0.00013	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.5e-05	0.000129	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.49e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—malignant glioma	1.47e-05	0.000127	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARG—malignant glioma	1.45e-05	0.000125	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.38e-05	0.000119	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARG—malignant glioma	1.33e-05	0.000115	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—malignant glioma	1.32e-05	0.000114	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.32e-05	0.000114	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAT—malignant glioma	1.29e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—malignant glioma	1.28e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAV1—malignant glioma	1.28e-05	0.00011	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.25e-05	0.000108	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.22e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOR1—malignant glioma	1.21e-05	0.000105	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.21e-05	0.000104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.17e-05	0.000101	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.15e-05	9.9e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—malignant glioma	1.14e-05	9.81e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARG—malignant glioma	1.13e-05	9.71e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.06e-05	9.1e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—malignant glioma	1.05e-05	9.02e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.03e-05	8.85e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—malignant glioma	1.02e-05	8.82e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—malignant glioma	9.92e-06	8.55e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAV1—malignant glioma	9.9e-06	8.53e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—malignant glioma	9.13e-06	7.87e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—malignant glioma	9.06e-06	7.8e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.01e-06	7.77e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.95e-06	7.71e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—malignant glioma	8.87e-06	7.64e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARG—malignant glioma	8.7e-06	7.5e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.92e-06	6.83e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—malignant glioma	7.73e-06	6.66e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—malignant glioma	7.4e-06	6.37e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—malignant glioma	7e-06	6.03e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.91e-06	5.95e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—malignant glioma	6.84e-06	5.9e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.44e-06	5.55e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—malignant glioma	5.97e-06	5.14e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—malignant glioma	5.72e-06	4.93e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.46e-06	4.7e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—malignant glioma	5.26e-06	4.53e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—malignant glioma	4.46e-06	3.84e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.21e-06	3.63e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—malignant glioma	3.44e-06	2.96e-05	CbGpPWpGaD
